Close

VYGR and NVS Related Headlines

Go Back

Jan 2, 2024 07:01AM Voyager Therapeutics (VYGR) Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies

VYGR and NVS Related Press Releases

Go Back

VYGR and NVS Related SEC Filings

Go Back